FDA inspection
Allergan Sales, LLC: FDA inspection ending Dec 15, 2000
FDA inspection 56058 · Voluntary Action Indicated (VAI) · Waco, TX
Key facts
| Inspection ID | 56058 |
|---|---|
| Firm | Allergan Sales, LLC |
| FEI number | 1643525 |
| Address | 8301 Mars Dr |
| City | Waco |
| State | TX |
| ZIP | 76712-6578 |
| Fiscal year | 2001 |
| Inspection end date | Dec 15, 2000 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation |
| Product type | Devices, Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data